$20.93 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About XOMA

XOMA Corporation is a biopharmaceutical company that develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.

Stock Analysis

last close $20.93
1-mo return -10.2%
3-mo return -12.1%
avg daily vol. 31.49T
52-week high 44.5
52-week low 19.4
market cap. $241M
forward pe 12.3
annual div. -
roe 5.9%
ltg forecast -
dividend yield -
annual rev. $30M
inst own. 60.5%

Subscribe now for daily local and international financial news